These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24004351)

  • 1. Growing experience with mTOR inhibitors in pediatric solid organ transplantation.
    Ganschow R; Pape L; Sturm E; Bauer J; Melter M; Gerner P; Höcker B; Ahlenstiel T; Kemper M; Brinkert F; Sachse MM; Tönshoff B
    Pediatr Transplant; 2013 Nov; 17(7):694-706. PubMed ID: 24004351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients.
    Nashan B
    Clin Transplant; 2013; 27 Suppl 25():16-29. PubMed ID: 23909498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?
    Gonzalez-Vilchez F; Vazquez de Prada JA; Paniagua MJ; Gomez-Bueno M; Arizon JM; Almenar L; Roig E; Delgado J; Lambert JL; Perez-Villa F; Sanz-Julve ML; Crespo-Leiro M; Segovia J; Lopez-Granados A; Martinez-Dolz L; Mirabet S; Escribano P; Diaz-Molina B; Farrero M; Blasco T
    Int J Cardiol; 2014 Jan; 171(1):15-23. PubMed ID: 24309084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.
    Shihab F; Christians U; Smith L; Wellen JR; Kaplan B
    Transpl Immunol; 2014 Jun; 31(1):22-32. PubMed ID: 24861504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR inhibitors in pediatric kidney transplantation.
    Pape L; Ahlenstiel T
    Pediatr Nephrol; 2014 Jul; 29(7):1119-29. PubMed ID: 23740036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of 4-year analysis of conversion from calcineurin inhibitors to mTOR inhibitors in renal transplant patients: single-center experience.
    Sert M; Celik A; Kural K; Ersan S; Ataca P; Atila K; Cavdar C; Sifil A; Bora S; Gulay H; Camsari T
    Ren Fail; 2011; 33(8):789-94. PubMed ID: 21787153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evidence on the use of anti-mTOR drugs in renal transplantation.
    Hernández D; Martínez D; Gutiérrez E; López V; Gutiérrez C; García P; Cobelo C; Cabello M; Burgos D; Sola E; González-Molina M
    Nefrologia; 2011; 31(1):27-34. PubMed ID: 21270910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study.
    Holdaas H; Rostaing L; Serón D; Cole E; Chapman J; Fellstrøm B; Strom EH; Jardine A; Midtvedt K; Machein U; Ulbricht B; Karpov A; O'Connell PJ;
    Transplantation; 2011 Aug; 92(4):410-8. PubMed ID: 21697773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation?
    Zeier M; Van Der Giet M
    Transpl Int; 2011 Jan; 24(1):30-42. PubMed ID: 20642495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term maintenance therapy with calcineurin inhibitors: an update.
    Campistol JM
    Transplant Proc; 2010 Nov; 42(9 Suppl):S21-4. PubMed ID: 21095445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of mTOR inhibitors in adult solid organ transplantation.
    Ventura-Aguiar P; Campistol JM; Diekmann F
    Expert Opin Drug Saf; 2016; 15(3):303-19. PubMed ID: 26667069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus in clinical practice in long-term liver transplantation: an observational study.
    Casanovas T; Argudo A; Peña-Cala MC
    Transplant Proc; 2011; 43(6):2216-9. PubMed ID: 21839237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to everolimus in liver transplant patients with renal dysfunction.
    Pérez T; Segovia R; Castro L; Roblero JP; Estela R
    Transplant Proc; 2011; 43(6):2307-10. PubMed ID: 21839260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibitor-associated proteinuria in kidney transplant recipients.
    Diekmann F; Andrés A; Oppenheimer F
    Transplant Rev (Orlando); 2012 Jan; 26(1):27-9. PubMed ID: 22137729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with everolimus is associated with a procoagulant state.
    Baas MC; Gerdes VE; Ten Berge IJ; Heutinck KM; Florquin S; Meijers JC; Bemelman FJ
    Thromb Res; 2013 Aug; 132(2):307-11. PubMed ID: 23906938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function in children with heart transplantation after switching to CNI-free immunosuppression with everolimus.
    Behnke-Hall K; Bauer J; Thul J; Akintuerk H; Reitz K; Bauer A; Schranz D
    Pediatr Transplant; 2011 Dec; 15(8):784-9. PubMed ID: 21883744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P; Metselaar HJ; Fischer L; Dumortier J; Boudjema K; Hardwigsen J; Rostaing L; De Carlis L; Saliba F; Nevens F
    Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation.
    Peddi VR; Wiseman A; Chavin K; Slakey D
    Transplant Rev (Orlando); 2013 Oct; 27(4):97-107. PubMed ID: 23932018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.
    Acquazzino MA; Fischer RT; Langnas A; Coulter DW
    Pediatr Transplant; 2013 Aug; 17(5):466-71. PubMed ID: 23730873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical insights for cancer outcomes in renal transplant patients.
    Alberú J
    Transplant Proc; 2010 Nov; 42(9 Suppl):S36-40. PubMed ID: 21095450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.